The educational content in this post, elaborated in collaboration with Lesaffre, was independently developed and approved by the GMFH publishing team and editorial board.
Antibiotics may cause an irreversible depletion of gut bacteria
Since 2000, global antibiotic use has increased by 66% and continues to rise at a rapid pace1. While antibiotics are a cornerstone of modern medicine, saving countless lives each year, they can also disrupt the delicate balance of the gut ecosystem. The gut bacteria most impacted by antibiotics include the Bacteroidetes, Firmicutes, and Actinobacteria taxa. These groups play crucial roles in the gut microbiome, such as metabolizing dietary fiber and polyphenols, synthesizing vitamins, regulating the immune system, maintaining gut barrier integrity, and protecting against enteric pathogens2.
The loss of gut microbiome diversity directly leads to the formation of a new ecosystem where beneficial bacteria may be unable to control Clostridioides difficile and other pathogenic bacteria that naturally reside in the gut, such as C. perfringens, Staphylococcus aureus, and Klebsiella oxytoca. These pathogens can overgrow when the gut microbiota that keeps them under control is wiped out2,3.
Beyond the loss of protective bacteria, the overuse of antibiotics—particularly when they are not the appropriate treatment—is a key factor in the development of antibiotic-resistant pathogens. This occurs through the natural selection of bacteria that that are more resistant to the drugs. As a result, there is an overgrowth of antibiotic-resistant bacteria, some of which are capable of degrading antibiotics within the gut, which in turn shields other pathogens from the antibiotics’ effects, ultimately leading to a decline in their effectiveness4. Yet, other resistance mechanisms apply as well. The proliferation of drug-resistant microbes is responsible for more than one million deaths and is recognized by the Centers for Disease Control and Prevention as a major threat to public health5.
Exposure to antibiotics can have long-term health consequences
Exposure to antibiotics in infancy is associated with an increased lifetime risk of infections, asthma, obesity, inflammatory bowel disease, and neurodevelopmental disorders. These effects are largely due to antibiotics’ ability to disrupt the gut microbiome, leading to increased intestinal permeability and inflammation, reduced levels of short-chain fatty acids, and altered immune cell development6.
Antibiotics can have long-lasting effects on adults’ gut microbiomes. Recent studies involving healthy adults found that gut microbiome diversity was impacted as early as one day after the treatment ended and remained altered for up to six months7,8. The gut microbiome of these healthy participants taking antibiotics temporarily resembled that of a patient in the intensive care unit9. In addition, the gut microbiome of some people taking antibiotics may serve as a reservoir for resistance genes that could be passed on to others10. Antibiotics may cause the gut microbiome to shift to an alternative stable state, the full implications of which are only now becoming clearer10-12.
How can you mitigate the side effects of antibiotics? Here’s what the latest science suggests
The side effects of antibiotics—such as diarrhea, gas, cramping, and nausea—are often due to a reduction in the microbial richness and diversity of the gut microbiome. To maintain or restore the gut microbiome after antibiotic use, current strategies include community replacement with probiotics or the administration of prebiotics3.
The best available scientific evidence suggests that some probiotics may have a moderate effect for preventing antibiotic-associated diarrhea in children, adults, and elderly adults13. This is explained by the capacity of probiotics to stimulate short-chain fatty acids production, protect the resident gut microbiome and gut barrier integrity, and protect against local inflammation14. However, this benefit is strain-specific, meaning that not all probiotics show efficacy for antibiotic-associated diarrhea13,14.
Not all probiotics are effective for recovering gut health after antibiotic use15. However, two well-researched probiotics, the yeast Saccharomyces boulardii CNCM I-745 and the bacterium Lacticaseibacillus rhamnosus GG, have shown promise, particularly in children and adults at risk of antibiotic-associated diarrhea13,14. Yeast probiotics offer advantages over bacterial probiotics, including better survival in the harsh conditions of the stomach, which allows them to reach the small and large intestines in an active state, and they can continue to be effective when administered alongside antibiotics16.
To maximize the benefits of probiotics, they should be introduced at the start of antibiotic treatment, with higher doses generally proving more effective than lower ones. In most clinical trials, probiotics were administered for the duration of antibiotic treatment and an additional seven days afterward. However, the best duration of probiotics after the cessation of antibiotics that allows the recovery of the gut ecosystem is unknown17.
A low-fiber diet may exacerbate the impact of antibiotics on the gut microbiome, delaying recovery, which suggests that prebiotic fibers are also important for the recovery of the gut microbiome after antibiotic use18. Prebiotics such as mucin glycans and xanthan gum may promote the growth of beneficial gut microorganisms of the microbiome, prevent the colonization of pathogenic bacteria, and boost the production of short-chain fatty acids in the gut following antibiotics3. After completing an antibiotic course, consuming foods rich in fermentable fiber may help restore healthy gut bacteria and is associated with reduced antibiotic resistance19.
Other potential tools for restoring gut health post-antibiotics, though not yet widely available, include fecal microbiota transfers. Administering a fecal microbiota transfer from the same individual could lead to faster microbiome restoration20, as could the use of defined communities of microorganisms, such as live purified or synthetic microbial consortia3. Scientists are also exploring using non-antibiotic drugs alongside antibiotics to enhance their effectiveness without harming beneficial gut bacteria21. Additional strategies to mitigate the consequences of antibiotic use include reducing gut antibiotic levels through enzymatic degradation or sequestration, which helps minimize broader negative impacts on the composition and function of the gut microbiome3.
References:
- Mamieva Z, Poluektova E, Svistushkin V, et al. Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations? World J Gastroenterol. 2022; 28(12):1204-1219. doi: 10.3748/wjg.v28.i12.1204.
- Ramirez J, Guarner F, Bustos Fernandez L, et al. Antibiotics as major disruptors of gut microbiota. Front Cell Infect Microbiol. 2020; 10:572912. doi: 10.3389/fcimb.2020.572912.
- Fishbein SRS, Mahmud B, Dantas G. Antibiotic perturbation to the gut microbiome. Nat Rev Microbiol. 2023; 21(12):772-788. doi: 10.1038/s41579-023-00933-y.
- Gjonbalaj M, Keith JW, Do MH, et al. Antibiotic degradation by commensal microbes shields pathogens. Infect Immun. 2020; 88(4):e00012-20. doi: 10.1128/IAI.00012-20.
- Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022; 399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0.
- Huang H, Jiang J, Wang X, et al. Exposure to prescribed medication in early life and impacts on gut microbiota and disease development. EClinicalMedicine. 2024: 68:102428. doi: 10.1016/j.eclinm.2024.102428.
- Anthony WE, Wang B, Sukhum KV, et al. Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults. Cell Rep. 2022; 39(2):110649. doi: 10.1016/j.celrep.2022.110649.
- Palleja A, Mikkelsen KH, Forslund SK, et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat Microbiol. 2018; 3(11):1255-1265. doi: 10.1038/s41564-018-0257-9.
- Sukhum KV, Newcomer EP, Cass C, et al. Antibiotic-resistant organisms establish reservoirs in new hospital built environments and are related to patient blood infection isolates. Commun Med. 2022; 2:62. doi: 10.1038/s43856-022-00124-5.
- de Nies L, Kobras CM, Stracy M. Antibiotic-induced colateral damage to the microbiota and associated infections. Nat Rev Microbiol. 2023; 21(12):789-804. doi: 10.1038/s41579-023-00936-9.
- Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. PNAS. 2011; 108(Suppl 1):4554-4561. doi: 10.1073/pnas.1000087107.
- Haak BW, Lankelma JM, Hugenholtz F, et al. Long-term impact of oral vancomycin, ciprofloxacin and metronidazole on the gut microbiota in healthy humans. J Antimicrob Chemother. 2019; 74(3):782-786. doi: 10.1093/jac/dky471.
- Guarner F, Sanders ME, Szajewska H, et al. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics. J Clin Gastroenterol. 2024; 58(6):533-553. doi: 10.1097/MCG.0000000000002002.
- Waitzberg D, Guarner F, Hojsak I, et al. Can the evidence-based use of probiotics (notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) mitigate the clinical effects of antibiotic-associated dysbiosis? Adv Ther. 2024; 41(3):901-914. doi: 10.1007/s12325-024-02783-3.
- Montassier E, Valdés-Mas R, Batard E, et al. Probiotics impact the antibiotic resistance gene reservoir along the human GI tract in a person-specific and antibiotic-dependent manner. Nat Microbiol. 2021; 6(8):1043-1054. doi: 10.1038/s41564-021-00920-0.
- Klein SM, Elmer GW, McFarland LV, et al. Recovery and elimination of the biotherapeutic agent, Saccharomyces boulardii, in healthy human volunteers. Pharm Res. 1993; 10(11):1615-1619. doi: 10.1023/a:1018924820333.
- Goodman C, Keating G, Georgousopoulou E, et al. Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis. BMJ Open. 2021; 11(8):e043054. doi: 10.1136/bmjopen-2020-043054.
- Ng KM, Aranda-Díaz A, Tropini C, et al. Recovery of the gut microbiota after antibiotics depends on host diet, community context, and environmental reservoirs. Cell Host Microbe. 2019; 26(5):650-665.e4. doi: 10.1016/j.chom.2019.10.011.
- Oliver A, Xue Z, Villanueva YT, et al. Association of diet and antimicrobial resistance in healthy U.S. adults. mBio. 2022; 13(3):e0010122. doi: 10.1128/mbio.00101-22.
- Suez J, Zmora N, Zilberman-Schapira G, et al. Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell. 2018; 174(6):1406-1423.e16. doi: 10.1016/j.cell.2018.08.047.
- Maier L, Goemans CV, Wirbel J, et al. Unravelling the collateral damage of antibiotics on gut bacteria. Nature. 2021; 599(7883)120-124. doi: 10.1038/s41586-021-03986-2.